Capstone Holding Corp. — Director's Dealing 2011

Jan 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2011-01-01

Reporting Person: HOLLIMAN JOHN M III (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-01	Stock Option (Right to Buy)	$0.58	A	10000	Acquired	2021-01-01	Common Stock (10000)	Direct